A review of the recent advances in endoscopic retrograde cholangiography-guided intraductal radiofrequency ablation for malignant biliary strictures
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pancreatobiliary malignancy is relatively rare; however, it remains one of the most lethal malignancies and has a dismal prognosis. Endoscopic retrograde cholangiopancreatography (ERCP)-guided intraductal radiofrequency ablation (ID-RFA) is a promising, minimally invasive treatment for unresectable malignant biliary strictures by delivering high-frequency alternating current to the target tissue, leading to coagulative necrosis. Recent studies have provided evidence that ERCP-guided ID-RFA is a safe, well-tolerated, and effective adjunctive treatment in terms of stent patency as well as overall survival. Compared with other local treatments, such as photodynamic therapy, ERCP-guided ID-RFA has advantages, including ease of delivery, controlled application of thermal energy, low cost, and fewer systemic side effects, with an acceptable safety profile. ERCP-guided ID-RFA has been proposed as an attractive endobiliary ablative therapy and is regarded to be an adjuvant method for the palliative care of patients with unresectable malignant biliary strictures. However, due to the ongoing lack of comparative studies, the choice of local ablative therapy remains, in each case, an individual decision by the multidisciplinary team.
Abstract
Pancreatobiliary malignancy is relatively rare; however, it remains one of the most lethal malignancies and has a dismal prognosis. Endoscopic retrograde cholangiopancreatography (ERCP)-guided intraductal radiofrequency ablation (ID-RFA) is a promising, minimally invasive treatment for unresectable malignant biliary strictures by delivering high-frequency alternating current to the target tissue, leading to coagulative necrosis. Recent studies have provided evidence that ERCP-guided ID-RFA is a safe, well-tolerated, and effective adjunctive treatment in terms of stent patency as well as overall survival. Compared with other local treatments, such as photodynamic therapy, ERCP-guided ID-RFA has advantages, including ease of delivery, controlled application of thermal energy, low cost, and fewer systemic side effects, with an acceptable safety profile. ERCP-guided ID-RFA has been proposed as an attractive endobiliary ablative therapy and is regarded to be an adjuvant method for the palliative care of patients with unresectable malignant biliary strictures. However, due to the ongoing lack of comparative studies, the choice of local ablative therapy remains, in each case, an individual decision by the multidisciplinary team.
참고문헌 (40)
- Shah DR, "Current oncologic applications of radiofrequency ablation therapies", World J Gastrointest Oncol, 5, pp.71~80 (2013)
- Yousaf MN, "Role of radiofrequency ablation in the management of unresectable pancreatic cancer", Front Med (Lausanne), 7, pp.624997~ (2021)
- Testoni SGG, "Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer", Endosc Ultrasound, 9, pp.83~100 (2020)
- Jae Hee Cho, "Recent developments in endoscopic ultrasound-guided radiofrequency ablation for pancreatic lesions", International Journal of Gastrointestinal Intervention, 9(4), pp.170~176 (2020), 소화기인터벤션의학회[DOI]
- Brace C, "Thermal tumor ablation in clinical use", IEEE Pulse, 2, pp.28~38 (2011)
- Friedman M, "Radiofrequency ablation of cancer", Cardiovasc Intervent Radiol, 27, pp.427~434 (2004)
- Zacharoulis D, "Habib EndoHPB: a novel endobiliary radiofrequency ablation device. An experimental study", J Invest Surg, 26, pp.6~10 (2013)
- Itoi T, "Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver", J Hepatobiliary Pancreat Sci, 19, pp.543~547 (2012)
- Kang H, "Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL", Surg Endosc, 35, pp.63~73 (2021)
- Cho JH, "Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model", J Gastroenterol Hepatol, 32, pp.521~526 (2017)
- Cho JH, "Long-term results of temperature-controlled endobiliary radiofrequency ablation in a normal swine model", Gastrointest Endosc, 87, pp.1147~1150 (2018)
- Kasugai H, "Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients", Oncology, 72(Suppl 1), pp.72~75 (2007)
- Lao OB, "Adverse events after radiofrequency ablation of unresectable liver tumors: a single-center experience", Am J Surg, 198, pp.76~82 (2009)
- Tal AO, "Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction", World J Gastrointest Endosc, 6, pp.13~19 (2014)
- Dolak W, "Endoscopic radiofrequency ablation for malignant biliary obstruction:a nationwide retrospective study of 84 consecutive applications", Surg Endosc, 28, pp.854~860 (2014)
- Sharaiha RZ, "Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry", Dig Dis Sci, 60, pp.2164~2169 (2015)
- Laleman W, "A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study", Endoscopy, 49, pp.977~982 (2017)
- Yang J, "Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma:a randomized trial", Endoscopy, 50, pp.751~760 (2018)
- Lee YN, "The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: a prospective multicenter study", J Gastroenterol Hepatol, 34, pp.1454~1459 (2019)
- Kim EJ, "Intraductal temperaturecontrolled radiofrequency ablation in malignant hilar obstruction: a preliminary study in animals and initial human experience", Endosc Int Open, 7, pp.E1293~E1300 (2019)
- Kim EJ, "Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: a clinicopathological study", PLoS One, 13, pp.e0206694~ (2018)
- Steel AW, "Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction", Gastrointest Endosc, 73, pp.149~153 (2011)
- Figueroa-Barojas P, "Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique", J Oncol, 2013, pp.910897~ (2013)
- Alis H, "Endobiliary radiofrequency ablation for malignant biliary obstruction", Hepatobiliary Pancreat Dis Int, 12, pp.423~427 (2013)
- Kallis Y, "Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit", Dig Dis Sci, 60, pp.3449~3455 (2015)
- Laquière A, "Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma", Surg Endosc, 30, pp.1242~1248 (2016)
- Wang F, "Endoscopic radiofrequency ablation for malignant biliary strictures", Exp Ther Med, 11, pp.2484~2488 (2016)
- Schmidt A, "Shortterm effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma", United European Gastroenterol J, 4, pp.570~579 (2016)
- Sharaiha RZ, "Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?", Dig Dis Sci, 59, pp.3099~3102 (2014)
- Bokemeyer A, "Endoscopic radiofrequency ablation prolongs survival of patients with unresectable hilar cholangiocellular carcinoma - a case-control study", Sci Rep, 9, pp.13685~ (2019)
- Gao DJ, "Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial", Gastrointest Endosc (2020)[DOI]
- Yang J, "Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma", Gastrointest Endosc, 92, pp.1204~1212.e1 (2020)
- Hu B, "Initial experience of ERCPguided radiofrequency ablation as the primary therapy for inoperable ampullary carcinomas", Dig Dis Sci, 65, pp.1453~1459 (2020)
- Sofi AA, "Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis", Gastrointest Endosc, 87, pp.944~951.e1 (2018)
- Rustagi T, "Radiofrequency ablation for intraductal extension of ampullary neoplasms", Gastrointest Endosc, 86, pp.170~176 (2017)
- Camus M, "Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study", Gastrointest Endosc, 88, pp.511~518 (2018)
- 조재희, "Intraductal Radiofrequency Ablation for Residual Adenoma after Endoscopic Papillectomy: An Additional Treatment Modality Expected to Be Safe and Effective", Gut and Liver, 15(2), pp.151~152 (2021), 거트앤리버 소화기연관학회협의회[DOI]
- Choi Young Hoon, "The Safety of Radiofrequency Ablation Using a Novel Temperature-Controlled Probe for the Treatment of Residual Intraductal Lesions after Endoscopic Papillectomy", Gut and Liver, 15(2), pp.307~314 (2021), 거트앤리버 소화기연관학회협의회[DOI]
- So H, "Feasibility and safety of endoluminal radiofrequency ablation as a rescue treatment for bilateral metal stent obstruction due to tumor ingrowth in the hilum: a pilot study", J Clin Med, 10, pp.952~ (2021)
- Nayar MK, "Novel temperature-controlled RFA probe for treatment of blocked metal biliary stents in patients with pancreaticobiliary cancers: initial experience", Endosc Int Open, 6, pp.E513~E517 (2018)